Despite the excitement and relief brought by news of highly effective COVID-19 vaccines that will likely soon be approved by U.S. regulators, their large-scale manufacturing and distribution is wrought with issues and complexities.
Lefkowitz’s memoir “A Funny Thing Happened on the Way to Stockholm: The Adrenaline-Fueled Adventures of an Accidental Scientist” is set to be released in February of next year. The story builds up to the 2012 Nobel Prize in Chemistry that he shared with his mentee Brian Kobilka. He also shares his experiences as a trained cardiologist who was diagnosed with a heart disease.
Colleges’ decisions to reopen this fall have raised concerns that outbreaks on campus could lead to COVID-19 spreading in college towns. However, a recent geospatial analysis by researchers at Duke and the University of North Carolina at Chapel Hill found little evidence that student cases of COVID-19 at a sample of North Carolina universities had spilled over into the wider community.
A Bass Connections team is researching how the pandemic might impact sexual behavior and sexual health among college students in the Triangle.
After the retraction of a study on hydroxychloroquine with data provided by a Duke alum's company, a Duke study on the drug has felt ripple effects.
Mark McClellan, founding director of the Duke-Margolis Center for Health Policy, spoke on Wednesday to the House Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce as part of a panel of public health scholars.
A global pandemic has upended many facets of life—including the environment.
Segregation in the 20th century contributed to a still-strained relationship between Durham and the Duke Hospital, two Duke professors told a virtual audience at a Tuesday event.
Students heard about health-care policy, voting and more at a Wednesday event.
Why has the COVID-19 pandemic disproportionately affected Black and brown people in the United States?
As precautionary measures taken to prevent the spread of COVID-19 continue, one question is on all of our minds: When is a safe, effective vaccine going to be developed?
Black women with natural hairstyles are commonly perceived by job recruiters as less professional, according to new research from the Fuqua School of Business.
A team of Duke researchers received $7.6 million in federal funds to develop an RNA-based antibody treatment for the prevention of COVID-19. Manufacturing will begin later this year and a Phase 1 clinical trial is on track to begin in early 2021.
COVID-19 has highlighted systemic issues, experts agreed at a Thursday discussion—ones that can’t be resolved with a vaccine.
Masks are the center of new debate following an article by Duke researchers that many took as a warning to not wear neck gaiters.
Breast cancer is a painful illness to endure and a painstaking one to treat, but a team of Duke researchers may have found a two-part solution that could help treat the disease.
Duke professors are studying and identifying ways to mitigate the disproportionate spread of COVID-19 in Durham’s Latinx community.
Pain is a complex process that is difficult to endure and even more difficult to understand. Duke researchers have made a discovery about mice that they hope could help treat it in humans.
After a national search, the Duke University School of Medicine named Adrian Hernandez the new vice dean and executive director of the Duke Clinical Research Institute last month.
Under the leadership of Curtis Richardson, director of the DUWC and professor of resource ecology at the Nicholas School of the Environment, Duke’s prowess in the field of wetland conservation and rehabilitation has grown. Now, the center plans to partner with Duke’s Marine Lab and Brian Silliman, the Rachel Carson professor of marine conservation biology at the Nicholas School.
